Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-03 6:59 pm Sale | 13D | Haleon plc HLN | PFIZER INC PFE | 1,361,709,764 15.000% | -700,526,315 (-33.97%) | View |
| 2024-10-01 7:38 pm Unchanged | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | View |
| 2024-08-05 6:12 pm Sale | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 0 0.000% | -27,349,211 (Position Closed) | View |
| 2024-07-29 4:33 pm Unchanged | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | View |
| 2024-03-22 09:05 am Sale | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | -892,827,547 (-30.21%) | View |
| 2024-03-19 8:48 pm Unchanged | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | View |
| 2024-03-15 07:45 am Unchanged | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 4.960% | 0 (Unchanged) | View |
| 2024-02-14 3:48 pm Purchase | 13G | eFFECTOR Therapeutics, Inc. EFTR | PFIZER INC PFE | 2,243,850 3.470% | 2,243,850 (New Position) | View |
| 2024-02-14 3:31 pm Purchase | 13G | Enliven Therapeutics, Inc. ELVN | PFIZER INC PFE | 389,429 0.950% | 389,429 (New Position) | View |
| 2024-02-14 2:29 pm Purchase | 13G | AN2 Therapeutics, Inc. ANTX | PFIZER INC PFE | 1,362,499 4.580% | 1,362,499 (New Position) | View |
| 2024-02-14 2:24 pm Purchase | 13G | Cellectis S.A. CLLS | PFIZER INC PFE | 2,786,924 3.890% | 2,786,924 (New Position) | View |
| 2024-02-14 2:19 pm Unchanged | 13G | Akero Therapeutics, Inc. AKRO | PFIZER INC PFE | 2,525,252 4.530% | 0 (Unchanged) | View |
| 2024-02-13 5:12 pm Purchase | 13G | Pfizer Inc. PFE | The Vanguard Group - 23-1945930 | 506,479,807 8.970% | 4,843,587 (+0.97%) | View |
| 2024-01-29 5:01 pm Sale | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 0 0.000% | -3,978,540 (Position Closed) | View |
| 2024-01-29 1:04 pm Purchase | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 287,875,814 5.100% | 2,932,117 (+1.03%) | View |
| 2024-01-26 11:49 am Sale | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 434,748,255 7.700% | -8,120,506 (-1.83%) | View |
| 2024-01-19 4:20 pm Unchanged | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | View |
| 2024-01-10 4:12 pm Unchanged | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 11.260% | 0 (Unchanged) | View |
| 2023-10-27 4:01 pm Purchase | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 6.260% | 1,272,214 (New Position) | View |
| 2023-10-25 5:29 pm Unchanged | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 13.140% | 0 (Unchanged) | View |